Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Autor: | Barbara E. K. Klein, Mohan Rema, Miho Yasuda, Jie Jin Wang, Ecosse L. Lamoureux, Ronald Klein, Paul Mitchell, Tien Yin Wong, Hugh R. Taylor, Jakob Grauslund, James M. Tielsch, Toke Bek, M. Kamran Ikram, Astrid E. Fletcher, Sophie Rogers, Xinzhi Zhang, Tarun Sharma, Jonathan E. Shaw, Massimo Porta, Ningli Wang, Trevor J. Orchard, Korapat Mayurasakorn, Sannapaneni Krishnaiah, J. P. O'Hare, Liang Xu, Sheila K. West, Rohit Varma, Jacqueline M. Dekker, Richard F. Hamman, Steven M. Haffner, Ryo Kawasaki, Monique S. Roy, Joanne W.Y. Yau, Takamasa Kayama, Shih-Jen Chen, Jonathan W. Kowalski |
---|---|
Přispěvatelé: | Interne Geneeskunde, RS: CARIM School for Cardiovascular Diseases, Ophthalmology, Epidemiology and Data Science, EMGO - Lifestyle, overweight and diabetes |
Rok vydání: | 2012 |
Předmět: |
Adult
Blood Glucose Male Gerontology medicine.medical_specialty Endocrinology Diabetes and Metabolism Population Blood Pressure 030209 endocrinology & metabolism Type 2 diabetes Young Adult 03 medical and health sciences 0302 clinical medicine SDG 3 - Good Health and Well-being Risk Factors Internal medicine Diabetes mellitus Prevalence Internal Medicine medicine Intraretinal microvascular abnormalities Humans Epidemiology/Health Services Research education Original Research Aged Glycemic Advanced and Specialized Nursing education.field_of_study Diabetic Retinopathy business.industry Diabetic retinopathy Middle Aged medicine.disease Middle age 3. Good health Hemoglobin A 030221 ophthalmology & optometry Female business |
Zdroj: | Diabetes Care, 35(3), 556-564. American Diabetes Association Diabetes Care, 35(3), 556-564. American Diabetes Association Inc. Yau, J W Y, Rogers, S L, Kawasaki, R, Lamoureux, E L, Kowalski, J W, Bek, T, Chen, S-J, Dekker, J M, Fletcher, A, Grauslund, J, Haffner, S, Hamman, R F, Ikram, M K, Kayama, T, Klein, B E K, Klein, R, Krishnaiah, S, Mayurasakorn, K, O'Hare, J P, Orchard, T J, Porta, M, Rema, M, Roy, M S, Sharma, T, Shaw, J, Taylor, H, Tielsch, J M, Varma, R, Wang, J J, Wang, N, West, S, Xu, L, Yasuda, M, Zhang, X, Mitchell, P, Wong, T Y & Meta-Analysis for Eye Disease (META-EYE) Study Group 2012, ' Global prevalence and major risk factors of diabetic retinopathy ', Diabetes Care, vol. 35, no. 3, pp. 556-64 . https://doi.org/10.2337/dc11-1909 Diabetes Care Yau, J W Y, Rogers, S L, Kawasaki, R, Lamoureux, E L, Kowalski, J W, Bek, T, Chen, S J, Dekker, J M, Fletcher, A, Grauslund, J, Haffner, S, Hamman, R F, Ikram, M K, Kayama, T, Klein, B E K, Klein, R, Krishnaiah, S, Mayurasakorn, K, O'Hare, J P, Orchard, T J, Porta, M, Rema, M, Roy, M S, Sharma, T, Shaw, J, Taylor, H, Tielsch, J M, Varma, R, Wang, J J, Wang, N L, West, S, Xu, L, Yasuda, M, Zhang, X Z, Mitchell, P & Wong, T Y 2012, ' Global Prevalence and Major Risk Factors of Diabetic Retinopathy ', Diabetes Care, vol. 35, no. 3, pp. 556-564 . https://doi.org/10.2337/dc11-1909 |
ISSN: | 0149-5992 1935-5548 |
DOI: | 10.2337/dc11-1909 |
Popis: | OBJECTIVE To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes. RESEARCH DESIGN AND METHODS A pooled analysis using individual participant data from population-based studies around the world was performed. A systematic literature review was conducted to identify all population-based studies in general populations or individuals with diabetes who had ascertained DR from retinal photographs. Studies provided data for DR end points, including any DR, proliferative DR, diabetic macular edema, and VTDR, and also major systemic risk factors. Pooled prevalence estimates were directly age-standardized to the 2010 World Diabetes Population aged 20–79 years. RESULTS A total of 35 studies (1980–2008) provided data from 22,896 individuals with diabetes. The overall prevalence was 34.6% (95% CI 34.5–34.8) for any DR, 6.96% (6.87–7.04) for proliferative DR, 6.81% (6.74–6.89) for diabetic macular edema, and 10.2% (10.1–10.3) for VTDR. All DR prevalence end points increased with diabetes duration, hemoglobin A1c, and blood pressure levels and were higher in people with type 1 compared with type 2 diabetes. CONCLUSIONS There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide. Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR. These data highlight the substantial worldwide public health burden of DR and the importance of modifiable risk factors in its occurrence. This study is limited by data pooled from studies at different time points, with different methodologies and population characteristics. |
Databáze: | OpenAIRE |
Externí odkaz: |